Other Cancers Comparing NALIRIFOX to Nab-Paclitaxel + Gemcitabine in Treatment-Naive Patients With mPDAC Aug 03, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) 1L Cemiplimab for laNSCLC: Updated Subgroup Analyses Aug 03, 2023
Bladder Cancer,Genitourinary Cancer,Other Cancers The Efficacy of Prophylactic Biologic Mesh on the PSH Development in Ileal Conduit Aug 03, 2023
Other Cancers 68Ga-FAP-2286 PET Imaging for Localized Bladder Cancer Shows Promising Results Aug 03, 2023
Leukemia,Other Cancers Ibrutinib Versus Placebo in Patients With Early-Stage CLL: CLL12 Trial Results Aug 03, 2023
Lymphoma,Other Cancers Liso-cel In R/R MCL: TRANSCEND NHL 001 Study Primary Analysis Results Aug 03, 2023
Esophageal Cancer,Gastrointestinal Cancer Pembrolizumab Plus Trastuzumab and Chemotherapy for HER2+ Metastatic G/GEJ cancer Aug 03, 2023
